Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Leave a Reply
Want to join the discussion?Feel free to contribute!
Leave a Reply
Feel free to contribute!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Job Position: CEO at Biothrust
Affiliation: BioThrust
Background: He has been CEO and Co-Founder of BioThrust since April 2022, a spin-off from RWTH Aachen University. The company’s core membrane aeration technology for bioreactors was developed during his PhD research in chemical process engineering, which he completed in 2023.
Prior to this, he studied biotechnology at RWTH Aachen University (M.Sc.) and at FH Aachen (B.Sc.).
He was awarded the Borchers Plaque in 2024 and won the Innovation Award of the German BioRegions in 2023.
He lives in his hometown of Neuss and was born in 1969.
Job Position: Head of Biology & Applications at Green Elephant Biotech
Affiliation: Green Elephant Biotech
Background: With over a decade of experience in stem cell biology, disease modeling, and cell therapy, she specializes in leading interdisciplinary collaborations to advance sustainable biotechnological innovations. At Green Elephant Biotech, she focuses on strategic partnerships and securing funding to promote scalable and accessible cell and gene therapies through innovative technology for dynamic adherent cell manufacturing.
Her expertise includes innovation management, strategic planning, grant proposal development, and stakeholder engagement. By collaborating closely with management, R&D, and commercial teams, she contributes to driving impactful solutions for the organization while fostering scientific communication and representation at global conferences.
Job Position: Future Founder of SMART-NK Therapeutics
Affiliation: SMART-NK Therapeutics
Background: He has a strong background in immunology and as a postdoctoral fellow he joined the group of Prof. Torsten Tonn and worked on understanding the immunological synapse of chimeric antigen receptor (CAR)-NK cells and dissecting cancer cell resistance to NK cell-based cell therapies.
Job Position: Chief Medical Officer of FamiCord
Affiliation: FamiCord AG
Background: Tomasz Baran is Chief Medical Officer of FamiCord – the largest cord blood bank in Europe and 3rd largest worldwide. He joined cord blood banking activity in 2010, prior to that he has been holding various position in pharmaceutical industry. In his current role Tomasz is responsible for medical communication on stem cell banking and use in therapies. He presented this topic on several international events – including Cord Blood Connect (USA), Perinatal Stem Cell Conference (USA) and Advanced Therapies (UK). Tomasz is also involved in development of cell&gene therapies manufacturing activity of FamiCord. Tomasz Baran serves ad Board of Directors member at Cord Blood Association (currently incorporated into AABB).
Job Position: Driving Multimodal AI in Precision Medicine
Affiliation: Fraunhofer IZI
Background: Ulrike Weirauch studied Molecular Life Science at the University of Lübeck and completed her doctorate in the research group of Achim Aigner at the Biochemical-Pharmacological Center of Philipps University Marburg in the field of cancer research.
She subsequently worked as a postdoctoral researcher in the Independent Division of Clinical Pharmacology at the Rudolf Boehm Institute of Pharmacology and Toxicology at Leipzig University.
Since 2021, she has been working as a scientist and science manager with Kristin Reiche in the Department of Medical Bioinformatics at the Fraunhofer Institute for Cell The
Job Position: Postdoc at Institute of Immunology, TU Dresden Coordinator, NCT Immune Monitoring Unit Dresden
Affiliation:
Background: Rebekka Wehner graduated in biology, did her Ph.D. and habilitation on dendritic cells. In the Institute of Immunology, medical faculty, TU Dresden, her research focuses on human immune cells like dendritic cells, monocytes/macrophages, natural killer cells, and T cells in the context of anti-tumor immune responses and therapies. Since 2016, she coordinates the NCT/UCC Immune Monitoring Unit Dresden, which offers an accompanying immune monitoring program during clinical studies. She supports the characterization of immune cells in blood, bone marrow, and tissues of tumor patients using multiplex flow cytometry and fluorescence-based immunohistochemistry.
Job Position: Consultant CMC
Affiliation: Consulting unit of hVIVO
Background: Ion Tcacencu, MD, PhD holds a doctorate from Karolinska Institutet in regenerative medicine and brings over 17 years of academic expertise in cell and tissue engineering. After transitioning into industry to lead quality and manufacturing at a cell therapy startup, he joined hVIVO as a CMC consultant. He supports academic ATMP developers with regulatory strategy, CMC development, market landscape analysis, and GMP-ready programmes — as well as technical due diligence for investors.
Job Position: Prof. for Rxperimental and Clinical CAR T Cell Therapy, Head of CAR T Cell Program
Affiliation: Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Dept. Of Internal Medicine 5 – Hematology & Oncology
Background: Prof. Müller obtained his MD in Freiburg, Germany and started his clinical education in Hamburg. With a focus on targeting malignant B cells from his early research career he did a postdoctoral fellowship with Dr. Ira Pastan, at the NCI on resistance to CD22-targeted therapy in ALL and aggressive lymphoma. After his post-doc he continued the work on B cell targeting in Erlangen, Germany using first antibody directed therapies and then CAR T cells with a focus on translational concepts including tumor microenvironment and functional aspects of a patient’s immune system. As head of the CAR T cell unit, he pioneers CAR T cell therapies in novel indications including solid tumors and autoimmune diseases.
Job Position: Director, Department of Hematology, Oncology, and Cell Therapy, University of Magdeburg
Affiliation: University of Magdeburg
Background: Prof. Dr. Dimitrios Mougiakakos is Director of the Department of Hematology, Oncology and Cell Therapy at Otto-von-Guericke University Magdeburg. He studied medicine in Hannover and trained in hematology and oncology in Freiburg, Regensburg, and Erlangen, with a research fellowship at the Karolinska Institute. He played a key role in the first clinical applications of CAR-T cell therapy for autoimmune diseases
BIOTYPE GmbH is an innovative solution provider for molecular precision diagnostics. We
offer a robust portfolio of profiling assays, alongside comprehensive CDMO services for the
development and manufacturing of diagnostic tests. BIOTYPE guides clients from initial
concept through sample testing to market-ready products.
The company develops and produces state‑of‑the‑art assays for the reliable detection of
DNA and RNA biomarkers, enabling personalized medicine and modern therapeutic
strategies.
BIOTYPE’s flexible and customizable CDMO solutions support diagnostic and
pharmaceutical partners in implementing complex molecular test systems. We cover projects
ranging from prototype development to RUO or CE‑IVD products and ensure compliance
with regulatory standards.
As part of the Molecular Diagnostics Group (MDG), BIOTYPE actively contributes to
advancing innovative diagnostic and therapeutic solutions. We aim to support early and
precise medical decision-making and development of safe and effective cell therapies.
You can visit their website here.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.